Galectin Therapeutics Inc. Stock Prediction
AI-powered sentiment analysis and prediction trends for GALT, updated each market day.
GALT AI Sentiment
AI predicts Galectin Therapeutics Inc. stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
Sector
Exchange
Market Cap
$159,960,698
Cap Tier
Employees
9
Headquarters
NORCROSS, GA
Listed Since
Sept. 4, 2002
GALT Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
GALT Volatility
Galectin Therapeutics Inc. has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
